CAS 6591-63-5|Quinidine sulfate dihydrate
| Common Name | Quinidine sulfate dihydrate | ||
|---|---|---|---|
| CAS Number | 6591-63-5 | Molecular Weight | 782.943 |
| Density | / | Boiling Point | 992.5ºC at 760 mmHg |
| Molecular Formula | C20H24N2O2.1/2H2O4S.H2O | Melting Point | 212-214 °C (dec.)(lit.) |
| MSDS | ChineseUSA | Flash Point | 554ºC |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | Quinidine sulfate salt dihydrate |
|---|---|
| Synonym | More Synonyms |
Quinidine sulfate dihydrate BiologicalActivity
| Description | Quinidine sulfate dihydrate is a potent and selective inhibitor of cytochrome P450db and inhibits amphetamine metabolism in vivo[1]. Quinidine sulfate dihydrate enhances the cytotoxicity of vincristine (VCR) in tumor cells and especially in VCR-resistant sublines of P388 leukemia (P388/VCR) and human myelogenous leukemia[2]. |
|---|---|
| Related Catalog | Research Areas >>CancerSignaling Pathways >>Metabolic Enzyme/Protease >>Cytochrome P450 |
| Target | IC50: cytochrome P450db; amphetamine metabolism[1] |
| References | [1]. David E. Moody, et al. Quinidine Inhibits In Vivo Metabolism of Amphetamine in Rats: Impact upon Correlation between GCIMS and Immunoassay Findings in Rat Urine. ournal of Analytical Toxicology, Vol. 14, September/October 1990 [2]. Tsuruo T, et al. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.Cancer Res. 1984 Oct;44(10):4303-7. |
Chemical & Physical Properties
| Boiling Point | 992.5ºC at 760 mmHg |
|---|---|
| Melting Point | 212-214 °C (dec.)(lit.) |
| Molecular Formula | C20H24N2O2.1/2H2O4S.H2O |
| Molecular Weight | 782.943 |
| Flash Point | 554ºC |
| Exact Mass | 782.356079 |
| PSA | 192.62000 |
| LogP | 6.52160 |
| Index of Refraction | 275 ° (C=2, 0.1mol/L HCl) |
| InChIKey | ZHNFLHYOFXQIOW-AHSOWCEXSA-N |
| SMILES | C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12.C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12.O.O.O=S(=O)(O)O |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 59 mg/kg
- TOXIC EFFECTS :
- Behavioral - convulsions or effect on seizure threshold Vascular - BP lowering not characterized in autonomic section Lungs, Thorax, or Respiration - other changes
- REFERENCE :
- JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 123,269,1958
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Precautionary Statements | P301 + P312 + P330 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn |
| Risk Phrases | R22 |
| Safety Phrases | 13-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | VA5605000 |
Articles8
More Articles| Comparative study of the effects of antituberculosis drugs and antiretroviral drugs on cytochrome P450 3A4 and P-glycoprotein. Antimicrob. Agents Chemother. 58(6) , 3168-76, (2014) Predicting drug-drug interactions (DDIs) related to cytochrome P450 (CYP), such as CYP3A4 and one of the major drug transporters, P-glycoprotein (P-gp), is crucial in the development of future chemoth... | |
| Diurnal variation in P-glycoprotein-mediated transport and cerebrospinal fluid turnover in the brain. AAPS J. 16(5) , 1029-37, (2014) Nearly all bodily processes exhibit circadian rhythmicity. As a consequence, the pharmacokinetic and pharmacodynamic properties of a drug may also vary with time of day. The objective of this study wa... | |
| Effects of the inhibition of intestinal P-glycoprotein on aliskiren pharmacokinetics in cynomolgus monkeys. Biopharm. Drug Dispos. 36(1) , 15-33, (2015) Aliskiren is a substrate for P-glycoprotein (P-gp) and is metabolized via cytochrome P450 3A4 (CYP3A4). The aim of the present study was to assess whether P-gp influenced the pharmacokinetics of alisk... |
Synonyms
| Quinidine Sulfate Dihydrate |
| Cinchonan-9-ol, 6'-methoxy-, (9S)-, sulfate, hydrate (2:1:2) (salt) |
| EINECS 200-046-3 |
| (9S)-6'-Methoxycinchonan-9-ol sulfate hydrate (2:1:2) |
| MFCD00149346 |
